Nomura Holdings’s RAPT Therapeutics RAPT Stock Holding History

Nomura Holdings’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,300	Closed	-$552K	–	2056
2025 Q4	$552K	Buy	+16,300	New	+$506K	﹤0.01%	1501

Nomura Holdings's RAPT Position: Q4 2024 in Review

Nomura Holdings sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 10,523 shares — an estimated $169K sold.

Nomura Holdings first reported a position in RAPT in Q3 2024 and held it in 1 quarter. The position peaked at $169K in Q3 2024. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

Nomura Holdings reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 10,523 RAPT Therapeutics shares in Q4 2024, an estimated $169K.
Nomura Holdings first reported a position in RAPT Therapeutics in Q3 2024 and held it in 1 quarter.
Nomura Holdings's RAPT Therapeutics position peaked at $169K in Q3 2024.
91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.